We are live on ! Find out more
II

Ibex Investors Portfolio holdings

AUM $152M
1-Year Est. Return 19.17%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
-19.17%
3 Year Est. Return
-4.48%
5 Year Est. Return
-29.66%
10 Year Est. Return
AUM
$1.22M
AUM Growth
-$1.12B
Cap. Flow
-$614M
Cap. Flow %
-50,145.52%
Top 10 Hldgs %
88.63%
Holding
111
New
55
Increased
19
Reduced
16
Closed
13

Top Buys

Rank Stock Value
1
RDHL
Redhill Biopharma
RDHL
+$6.86M
2
RDWR icon
Radware
RDWR
+$4.98M
3
SILC icon
Silicom
SILC
+$3.78M
4
DOX icon
Amdocs
DOX
+$3.53M
5
TSEM icon
Tower Semiconductor
TSEM
+$1.67M

Sector Composition

Rank Sector Weight
1 Consumer Staples 16.97%
2 Technology 8.67%
3 Healthcare 2.09%
4 Energy 1.18%
5 Consumer Discretionary 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
PUT
SPDR Gold Trust
GLD
$131B
$382K 31.22%
+28,700
New +$3.55M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$205K 16.75%
+7,000
New +$2.02M
STRA icon
3
Strategic Education
STRA
$1.71B
$205K 16.75%
+1,247
New +$204K
SVXY icon
4
ProShares Short VIX Short-Term Futures ETF
SVXY
$220M
$87.8K 7.17%
3,260,212
-301,818
-8% -$7.99M
XNTK icon
5
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
$60.6K 4.95%
+22,250
New +$1.61M
CBOE icon
6
CALL
Cboe Global Markets
CBOE
$29.8B
$42.2K 3.45%
+2,800,000
New +$290M
JJT
7
CALL
DELISTED
iPath Series B Bloomberg Tin Subindex Total ReturnSM ETN
JJT
$36.4K 2.97%
14,000
-4,316,000
-100% -$215M
UCD
8
CALL
DELISTED
PROSHARES ULTRA BLOOMBERG COMMODITY
UCD
$32.5K 2.65%
6,029
-596,871
-99% -$3.22M
SILC icon
9
Silicom
SILC
$228M
$16.7K 1.36%
513,369
+114,701
+29% +$3.78M
RDWR icon
10
Radware
RDWR
$1.24B
$16.6K 1.35%
670,000
+199,600
+42% +$4.98M
TSEM icon
11
Tower Semiconductor
TSEM
$26.4B
$15.8K 1.29%
1,000,000
+100,000
+11% +$1.67M
NVMI
12
Nova
NVMI
$13.9B
$15.4K 1.25%
600,103
+103
+0% +$2.75K
NBL
13
DELISTED
Noble Energy, Inc.
NBL
$13.4K 1.1%
600,000
RDHL
14
Redhill Biopharma
RDHL
$3.85M
$12.1K 0.99%
1,867
+891
+91% +$6.86M
VRNT
15
DELISTED
Verint Systems
VRNT
$10.8K 0.88%
392,600
-65,992
-14% -$1.98M
DOX icon
16
Amdocs
DOX
$5.53B
$8.86K 0.72%
142,750
+61,094
+75% +$3.53M
GLMD icon
17
Galmed Pharmaceuticals
GLMD
$3.94M
$5.93K 0.48%
4,486
+822
+22% +$1.06M
NVDA icon
18
NVIDIA
NVDA
$5.01T
$3.32K 0.27%
808,160
-558,000
-41% -$2.31M
GM icon
19
General Motors
GM
$74.7B
$3.24K 0.26%
84,013
+11,500
+16% +$431K
SPLK
20
DELISTED
Splunk Inc
SPLK
$3.11K 0.25%
24,762
-6,350
-20% -$807K
GOOG icon
21
Alphabet (Google) Class C
GOOG
$3.9T
$3.01K 0.25%
55,680
-21,000
-27% -$1.21M
CRNT icon
22
Ceragon Networks
CRNT
$194M
$2.64K 0.22%
900,000
-250,000
-22% -$818K
ITI
23
DELISTED
Iteris, Inc.
ITI
$2.45K 0.2%
474,290
SPCB icon
24
SuperCom
SPCB
$67.3M
$2.15K 0.18%
9,945
SCNI
25
Scinai Immunotherapeutics
SCNI
$1.19M
$2.07K 0.17%
3,590

Similar funds

Ibex Investors's Q2 2019 Portfolio in Review

As of Q2 2019, Ibex Investors held 111 positions worth $1.22M, down 100% from $1.12B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Ibex Investors withdrew a net $614M in Q2 2019, closing 13 positions and reducing 16 holdings. Its most notable exit was SolarEdge, an estimated $3.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, up from 0.2% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Ibex Investors opened a new position in Amazon worth $1.23K.

  • Ibex Investors's largest Q2 2019 buy was Amazon: 13,000 shares worth $1.23K.
  • Ibex Investors added most to Redhill Biopharma in Q2 2019, an estimated $6.86M increase.
  • Ibex Investors's biggest Q2 2019 reduction was ProShares Short VIX Short-Term Futures ETF, cutting an estimated $7.99M.
  • Ibex Investors fully exited SolarEdge in Q2 2019, selling an estimated $3.6M.
  • Ibex Investors's ten largest holdings make up 89% of its $1.22M portfolio in Q2 2019.
  • Ibex Investors opened 55 new positions and closed 13 in Q2 2019.
  • Ibex Investors's portfolio value fell 100% quarter-over-quarter to $1.22M.

Based on Ibex Investors's 13F filing for Q2 2019, filed 29 Jul 2019.